Contrasting Microbot Medical (NASDAQ:MBOT) and CVR Medical (OTCMKTS:CRRVF)

Microbot Medical (NASDAQ:MBOT) and CVR Medical (OTCMKTS:CRRVF) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership and dividends.

Earnings & Valuation

This table compares Microbot Medical and CVR Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$10.74 million	($0.80)	-2.41
CVR Medical	N/A	N/A	-$1.82 million	N/A	N/A

Profitability

This table compares Microbot Medical and CVR Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-218.30%	-158.17%
CVR Medical	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Microbot Medical and CVR Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	0	0	1	0	3.00
CVR Medical	0	0	0	0	0.00

Microbot Medical presently has a consensus price target of $7.00, suggesting a potential upside of 262.69%. Given Microbot Medical’s stronger consensus rating and higher probable upside, equities analysts clearly believe Microbot Medical is more favorable than CVR Medical.

Institutional and Insider Ownership

16.3% of Microbot Medical shares are owned by institutional investors. 10.5% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Microbot Medical beats CVR Medical on 5 of the 8 factors compared between the two stocks.

About Microbot Medical

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.